Reviews
Average rating: 3/5
Physician ( 1 )
-
5
-
4
-
3
-
2
-
1
Average rating: 3.00/5
Total Reviews: 1
-
5
-
4
-
3
-
2
-
1
Topical roflumilast is a non-steroidal PDE4 inhibitor approved for mild-to-moderate eczema and fits into the treatment algorithm as an alternative to topical corticosteroids or calcineurin inhibitors. It is particularly useful for patients who need long-term topical control or who experience side effects from steroids. For patients already on a systemic biologic, roflumilast may be used as an adjunct or alternative topical option to demonstrate adequate topical therapy when seeking insurance approval.
0